Academic Qualifications
| Qualification | Institution | Year of Completion |
|---|---|---|
| Master of Science (Biotechnology) | Universitas Indonesia | 2019 |
| Bachelor of Science (Chemistry) | Universitas Indonesia | 2015 |
Industry Experience
| Position | Organisation/Institution | Date of Tenure |
|---|---|---|
| Biotech researcher | Medion Group | March 2020 – October 2021 |
| Bioinformatics research fellow | Universitas Indonesia | February 2017 – January 2020 |
| Chemical analyst | PT Pertamina | December 2015 – January 2017 |
Fellowships/Memberships/Affiliations
| Organisation | Level |
|---|---|
| Indonesia Endownment Fund for Education (LPDP) | Awardee |
Selected Publications – industry/IP specific
| Publications |
|---|
| A. H. Alkaff et al., (First author), Identification of DNA methyltransferase-1 inhibitor for breast cancer therapy through computational fragment-based drug design, Molecules, 26(2), 375 (2021) |
| A. H. Alkaff et al., (First author), Zika, chikungunya, and dengue viral infections in human peripheral blood mononuclear cells: cell susceptibility and gene expression, Med. J. Indones. 29(2), 129-135 (2020) |
| M. A. F. Nasution, A. H. Alkaff et al., (3rd author of 5), Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola, BMC Bioinform. 19(14), 137-149 (2018) |
| U. S. F. Tambunan, A. H. Alkaff et al., (2nd author of 5), Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis, J. Mol. Graph. 74, 366-378 (2017) |
Experience and Technical Background
Experienced in the following areas of patent practice:
- Patent prosecution
Primary patent practice areas by technology:
- Chemistry
- Pharmaceuticals
- Biotechnology
Research/industry background:
A. General technical areas:
- Analytical Chemistry
- Bioinformatics
- Molecular Biology
- Virology
B. Scientific research:
- Arboviruses infection in human PBMC: cell susceptibility and cytokines expression
- In silico screening of conjugated peptide as inhibitor of Ebola virus glycoprotein
C. Industry experience:
- Development of avian influenza subunnit vaccine
- Fragment-based drug design of methyltransferase inhibitors
- Optimization of secondary oil recovery using polymer and surfactant